We are live on ! Find out more
ACHV icon

Achieve Life Sciences

63 hedge funds and large institutions have $42.3M invested in Achieve Life Sciences in 2014 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 14

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3% less funds holding

Funds holding: 6563 (-2)

10% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 20

40% less capital invested

Capital invested by funds: $70.9M → $42.3M (-$28.6M)

69% less call options, than puts

Call options by funds: $738K | Put options by funds: $2.35M

Holders
63
Holders Change
-2
Holders Change %
-3.08%
% of All Funds
1.81%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
18
Increased
21
Reduced
14
Closed
20
Calls
$738K
Puts
$2.35M
Net Calls
-$1.61M
Net Calls Change
+$516K

ACHV Hedge Fund Activity: Q2 2014 in Review

63 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q2 2014, worth a combined $42.3M — down 40% from $70.9M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of ACHV and 18 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 21 added.

The largest buyer was Great Point Partners, opening a new position worth an estimated $11.8M. The largest seller was BlackRock Fund Advisors, cutting an estimated $2.04M.

  • 63 institutional investors held Achieve Life Sciences (ACHV) as of Q2 2014, down from 65 in Q1 2014.
  • Funds reported $42.3M of Achieve Life Sciences stock for Q2 2014, down 40% quarter-over-quarter.
  • 18 funds opened new Achieve Life Sciences positions in Q2 2014 and 20 closed out, a net change of -2 holders.
  • The largest Achieve Life Sciences buyer in Q2 2014 was Great Point Partners, an estimated $11.8M added.
  • The largest Achieve Life Sciences seller in Q2 2014 was BlackRock Fund Advisors, an estimated $2.04M sold.

Based on aggregated 13F filings for Q2 2014.